Clinical Trial Update: Tipifarnib in Treating Patients With Advanced Hematologic Cancer [Phase 1]

View source ↗

Summary

This document reports the status of a Phase 1 clinical trial of tipifarnib for advanced hematologic cancers sponsored by the National Cancer Institute, which ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Plasma Cell Neoplasm

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Status: COMPLETED